The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

Research Highlights


Personalized medicine: T cells fight cancer

A very promising approach in fighting cancer is targeting mutations of cancer cells. Scientists at the MDC now can explain which mutations are suitable for therapy and why cell culture tests are sometimes not enough.



Blood vessels sprout under pressure

It is blood pressure that drives the opening of small capillaries during angiogenesis. A team of researchers led by Prof. Holger Gerhardt of the MDC observed the process for the first time and published their findings in Nature Cell Biology.



Nir Friedman

Humboldt award winner Nir Friedman to be guest researcher at the MDC

The internationally renowned systems biologist Prof. Nir Friedman of the Hebrew University of Jerusalem (HUJI) is this year’s recipient of the Humboldt Research Award. The MDC will be the host institution of Friedman in Germany. Here, he will collaborate with Prof. Nikolaus Rajewsky.


Captain T Cell

Team of MDC researchers winner of OneStart competition

It's a great success for the T cell therapy against cancer: "Captain T Cell", a project comprised of researchers of the Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) has won at the prestigious OneStart competiotion in London at May 16.


Intestinal flora

Healthy intestinal flora keeps the mind sharp – with some help from the immune system

Special immune cells connect gut bacteria and brain, as our researcher Dr. Susanne Wolf found out. The findings may help when it comes to long-term use of antibiotics and the treatment of mental disorders.